Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Senior Reporter
Virginia, USA
+5 year(s) experience
Medtech Insight
By Elizabeth Orr 18 Dec 2019
A proposal from the US FDA would end quarterly publication of PMA and Humanitarian Device Exemption verdicts in the Federal Register. The agency says the practice is inefficient and duplicates online publication.
Medtech Insight
By Elizabeth Orr 20 Nov 2019
A newly approved contact lens from CooperVision promises to slow the progression of nearsightedness when prescribed to children aged 8 to 12.
Topic FDA
Medtech Insight
By Elizabeth Orr 02 Jul 2019
Physicians and researchers in an all-day session at the Cardiovascular Research Technologies conference in Washington, DC, on March 5 largely backed the recent finding that paclitaxel-coated balloons and stents may be tied to a higher patient mortality rate. But the specific mechanism underlying the deaths remains unknown.
Topic Medtech
Medtech Insight
By Elizabeth Orr 07 Mar 2019
4C Medical plans to conduct both an early feasibility study and the pivotal trial for its mitral regurgitation treatment device simultaneously in Japan, the US and Canada. The company says the study is the first early feasibility study in Japan for an implantable device.
Topic Medtech
Medtech Insight
By Elizabeth Orr 07 Feb 2019
The US Department of Homeland Security National Cybersecurity and Communications Integration Center is warning of potential cybersecurity vulnerabilities in Stryker hospital beds and BD diagnostics equipment.
Medtech Insight
By Elizabeth Orr 23 Jan 2019
Despite pushback from industry, US FDA has moved forward with plans to establish a new alternative 510(k) pathway by finalizing a guidance document that describes the so-called “Safety and Performance Based Pathway” that emphasizes use of consensus standards instead of direct predicate comparisons.
Topic FDA
Medtech Insight
By Elizabeth Orr 05 Dec 2018
A US FDA panel overwhelmingly supported a heart-failure device designed to use cardiac contractility modulation to improve heart function. The Optimizer Smart system from Impulse Dynamics is apparently the first in FDA’s Breakthrough Devices program to go before an advisory panel.
Topic FDA
Medtech Insight
By Elizabeth Orr 18 Oct 2018
Two 510(k) pilots from US FDA indicate the agency's desire for faster, easier clearances. But some observers aren’t sure if they’ll lead to real improvements.
Topic FDA
Medtech Insight
By Elizabeth Orr 16 Oct 2017
The US agency is looking for ways to open its upcoming Voluntary Medical Device Manufacturing and Product Quality Program.
Medtech Insight
By Elizabeth Orr 24 Mar 2017
The 37 groups and individuals who submitted comments on FDA’s two draft guidances on next-generation sequencing issued in July expressed appreciation for the thinking behind the guidances, but found bones to pick with some details.
Medtech Insight
21 Feb 2020
Medtech Insight
14 Feb 2020
Medtech Insight
13 Feb 2020
Medtech Insight
11 Feb 2020
Medtech Insight
07 Feb 2020
Medtech Insight
06 Feb 2020
Medtech Insight
04 Feb 2020
Medtech Insight
11 Dec 2019
Medtech Insight
10 Dec 2019
Medtech Insight
06 Dec 2019
Medtech Insight
06 Dec 2019
Medtech Insight
29 Nov 2019
Medtech Insight
27 Nov 2019
Medtech Insight
27 Nov 2019
Medtech Insight
22 Nov 2019
Tweets from Elizabeth